• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

    5.605 +0.185 (+3.41%)
    Streaming Delayed Price Updated: 1:52 PM EDT, Jul 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,204,352
    Open 5.420
    Bid (Size) 5.600 (5,100)
    Ask (Size) 5.610 (2,900)
    Prev. Close 5.420
    Today's Range 5.390 - 5.720
    52wk Range 1.865 - 9.750
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale? ↗
    This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum ↗
    Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -34.7%
    -34.7%
    1 Month
    +13.0%
    +13.0%
    3 Month
    +24.3%
    +24.3%
    6 Month
    -37.4%
    -37.4%
    1 Year
    +188.9%
    +188.9%

    More News

    Read More
    News headline image
    Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Nuvation Bio (NYSE:NUVB) Soars 22% After Earnings Beat Fueled by Strong Lung Cancer Drug Launch ↗
    Via Chartmill
    Topics Earnings
    NUVATION BIO INC (NYSE:NUVB) Stock Plunges 9% After Q4 Earnings Reveal Revenue Beat but Wider Loss ↗
    Via Chartmill
    Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut ↗
    Via Stocktwits
    News headline image
    Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Nuvation Bio (NUVB) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction ↗
    Via The Motley Fool
    Topics ETFs Regulatory Compliance
    News headline image
    Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Which stocks are gapping on Tuesday? ↗
    Via Chartmill
    News headline image
    Nuvation Bio (NUVB) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
    From Nuvation Bio
    Via Business Wire
    News headline image
    Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
    From Nuvation Bio
    Via Business Wire
    News headline image
    Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
    From Nuvation Bio and Eisai
    Via Business Wire
    News headline image
    Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Nuvation Bio
    Via Business Wire
    News headline image
    Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
    From Nuvation Bio
    Via Business Wire
    News headline image
    Nuvation Bio to Participate in Upcoming Investor Conferences
    From Nuvation Bio
    Via Business Wire
    News headline image
    Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
    Via MarketMinute

    Frequently Asked Questions

    Is Nuvation Bio Inc. Class A Common Stock publicly traded?
    Yes, Nuvation Bio Inc. Class A Common Stock is publicly traded.
    What exchange does Nuvation Bio Inc. Class A Common Stock trade on?
    Nuvation Bio Inc. Class A Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Nuvation Bio Inc. Class A Common Stock?
    The ticker symbol for Nuvation Bio Inc. Class A Common Stock is NUVB on the New York Stock Exchange
    What is the current price of Nuvation Bio Inc. Class A Common Stock?
    The current price of Nuvation Bio Inc. Class A Common Stock is 5.605
    When was Nuvation Bio Inc. Class A Common Stock last traded?
    The last trade of Nuvation Bio Inc. Class A Common Stock was at 07/02/26 01:52 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.